Understanding the costs of drug-related actions is an important aspect of drug policy.
In the Netherlands, no budget is associated with the drug policy documents and there is no review of executed expenditures. In 2006, the results of a study that aimed to estimate overall drug-related public expenditures in the Netherlands was published.
The study estimated that in 2003 total drug-related public expenditures represented 0.5 % of gross domestic product (GDP). Most of the expenditures were attributed to law enforcement (75 %) and the remainder to treatment (13 %), harm reduction (10 %) and prevention (2 %).
The available data do not enable the total drug-related public expenditure in the Netherlands in recent years or trends in spending to be reported.